PCSK9 and the nervous system: a no-brainer?
Journal of Lipid Research, ISSN: 0022-2275, Vol: 64, Issue: 9, Page: 100426
2023
- 7Citations
- 16Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations7
- Citation Indexes7
- CrossRef2
- Captures16
- Readers16
- 16
- Mentions1
- News Mentions1
- News1
Most Recent News
PCSK9 and the nervous system: a no-brainer?
J Lipid Res. 2023 Aug 14;:100426. Authors: Jaafar AK, Techer R, Chemello K, Lambert G, Bourane S PubMed: 37586604 Submit Comment
Review Description
In the past 20 years, PCSK9 has been shown to play a pivotal role in LDL cholesterol metabolism and cardiovascular health by inducing the lysosomal degradation of the LDL receptor. PCSK9 was discovered by the cloning of genes up-regulated after apoptosis induced by serum deprivation in primary cerebellar neurons, but despite its initial identification in the brain, the precise role of PCSK9 in the nervous system remains to be clearly established. The present article is a comprehensive review of studies published or in print before July 2023 that have investigated the expression pattern of PCSK9, its effects on lipid metabolism as well as its putative roles specifically in the central and peripheral nervous systems, with a special focus on cerebrovascular and neurodegenerative diseases.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0022227523000998; http://dx.doi.org/10.1016/j.jlr.2023.100426; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85172425784&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/37586604; https://linkinghub.elsevier.com/retrieve/pii/S0022227523000998; https://dx.doi.org/10.1016/j.jlr.2023.100426
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know